We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Pharmacy, prescription-only (POM), and general sale list (GSL) medicines: apply to move your medicine to a different classification.
Information for manufacturers.
The UK’s consumer connectable product security regime came into effect on 29 April 2024. Businesses in the supply chains of these products now need to be compliant with the legislation.
Resources to help anyone developing or running a digital health product to conduct an evaluation.
There are changes to the legislation of Reference Medicinal Products (RMPs) used to support abridged marketing authorisation applications
Papers from the Office for Product Safety and Standards.
How to assess household and non-household packaging from 2024 onwards if you’re a UK organisation affected by extended producer responsibility (EPR) for packaging.
Information on OPSS product safety alerts, reports and recalls for unsafe products and resources for consumers, businesses and regulators.
How to create a model of how your digital health product works and choose measures for your evaluation.
The guide, toolkit and further information for GB authorities with responsibility for consumer product safety.
How to ensure the products you make or import comply with the law and are safe for consumers to use.
How we will deliver protection and confidence in a strong, green economy.
How to use a before-and-after study to evaluate your digital health product.
How a marketing authorisation holder should report a defect with a veterinary medicine.
How a product complies with EU safety, health and environmental requirements, and how to place a CE marking on your product.
How to use a combination of quantitative and qualitative data to evaluate your digital health product.
This guidance provides information on comparator products used in studies supporting abridged marketing authorisation applications
What you need to do to place a medical device on the Great Britain, Northern Ireland and European Union (EU) markets.
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
Guidance for the veterinary pharmaceutical industry on the production of mock-ups for assessment.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).